{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:31:48Z","timestamp":1793233908429,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017266","name":"Gobierno de Navarra","doi-asserted-by":"publisher","award":["46\/2016"],"award-info":[{"award-number":["46\/2016"]}],"id":[{"id":"10.13039\/501100017266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009664","name":"Sociedad Espa\u00f1ola de Cardiolog\u00eda","doi-asserted-by":"publisher","award":["SEC\/2016"],"award-info":[{"award-number":["SEC\/2016"]}],"id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI24\/00234"],"award-info":[{"award-number":["PI24\/00234"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hrthm.2026.10.002","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:13:10Z","timestamp":1791558790000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nuclear magnetic resonance-derived lipoprotein profile and risk of atrial tachyarrhythmia recurrence after catheter ablation: a case-cohort design within the PREDIMAR trial"],"prefix":"10.1016","author":[{"given":"Authors\u2019 names: Luc\u00eda","family":"Belzunce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Goni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Teresa","family":"Barrio-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Tercedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Ib\u00e1\u00f1ez Criado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Amig\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pol","family":"Torn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Razquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"de la O","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Ib\u00e1\u00f1ez-Criado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Mac\u00edas-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Mart\u00ednez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Garc\u00eda-Bolao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Almendral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7684-2787","authenticated-orcid":false,"given":"Miguel","family":"Ruiz-Canela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2026.10.002_bib1","unstructured":"Atrial fibrillation and flutter - Level 3 cause | Institute for Health Metrics and Evaluation [Internet]. [cited 2025 Jun 4],. Available from: https:\/\/www.healthdata.org\/research-analysis\/diseases-injuries-risks\/factsheets\/2021-atrial-fibrillation-and-flutter-level-3"},{"key":"10.1016\/j.hrthm.2026.10.002_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae195","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2021","volume":"26","author":"Cheng","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.10.002_bib3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2018.11.123","article-title":"The imminent epidemic of atrial fibrillation and its concomitant diseases \u2013 Myocardial infarction and heart failure - A cause for concern","volume":"287","author":"B\u00f6rschel","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tcm.2021.12.001","article-title":"Atrial fibrillation and stroke: A review and new insights","volume":"33","author":"Escudero-Mart\u00ednez","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.10.002_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jama.2024.22451","article-title":"Atrial Fibrillation","volume":"333","author":"Ko","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2026.10.002_bib6","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.10.002_bib7","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies\u2014a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.10.002_bib8","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/cvr\/cvab017","article-title":"Relationship between lipoproteins, thrombosis, and atrial fibrillation","volume":"118","author":"Ding","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2026.10.002_bib9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/CIRCEP.113.001378","article-title":"Paradoxical association of lipoprotein measures with incident atrial fibrillation","volume":"7","author":"Mora","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10840-019-00543-w","article-title":"Blood lipid levels and recurrence of atrial fibrillation after radiofrequency catheter ablation: a prospective study","volume":"57","author":"Shang","year":"2020","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"key":"10.1016\/j.hrthm.2026.10.002_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1258125","article-title":"Predictive value of remnant-like particle cholesterol in the prediction of long-term AF recurrence after radiofrequency catheter ablation","volume":"10","author":"Wu","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.10.002_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79836-8","article-title":"L-shaped association of plasma low-density lipoprotein cholesterol with atrial fibrillation recurrence after catheter ablation: a prospective cohort study","volume":"14","author":"Zou","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.hrthm.2026.10.002_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2022.960522","article-title":"Clinical relevance of nuclear magnetic resonance LipoProfile","volume":"2","author":"Emeasoba","year":"2022","journal-title":"Frontiers in nuclear medicine"},{"key":"10.1016\/j.hrthm.2026.10.002_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.trac.2017.07.009","article-title":"Quantification of lipoprotein profiles by nuclear magnetic resonance spectroscopy and multivariate data analysis","volume":"94","author":"Aru","year":"2017","journal-title":"TrAC Trends in Analytical Chemistry"},{"key":"10.1016\/j.hrthm.2026.10.002_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00395-019-0735-0","article-title":"Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number","volume":"114","author":"Trieb","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2019.10.009","article-title":"PREvention of recurrent arrhythmias with Mediterranean diet (PREDIMAR) study in patients with atrial fibrillation: Rationale, design and methods","volume":"220","author":"Barrio-Lopez","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2026.10.002_bib17","doi-asserted-by":"crossref","DOI":"10.2196\/21436","article-title":"A remote nutritional intervention to change the dietary habits of patients undergoing ablation of atrial fibrillation: randomized controlled trial","volume":"22","author":"Goni","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.hrthm.2026.10.002_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/22.3.512","article-title":"Development and validation of a food frequency questionnaire in Spain","volume":"22","author":"Martin-Moreno","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib19","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3945\/jn.110.135566","article-title":"A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women","volume":"141","author":"Schr\u00f6der","year":"2011","journal-title":"J Nutr"},{"key":"10.1016\/j.hrthm.2026.10.002_bib20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1079\/PHN2005745","article-title":"Validation of the Spanish version of the physical activity questionnaire used in the Nurses\u2019 Health Study and the Health Professionals\u2019 Follow-up Study","volume":"8","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2005","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.hrthm.2026.10.002_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.hrthm.2026.10.002_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s11306-011-0273-8","article-title":"Surface fitting of 2D diffusion-edited 1H NMR spectroscopy data for the characterisation of human plasma lipoproteins","volume":"7","author":"Mallol","year":"2011","journal-title":"Metabolomics"},{"key":"10.1016\/j.hrthm.2026.10.002_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1378\/chest.11-0523","article-title":"Correction for Multiple Testing: is there a resolution?","volume":"140","author":"Streiner","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2026.10.002_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyaf098","article-title":"Multiplicity corrections in life sciences: challenges and consequences","volume":"54","author":"Menyh\u00e1rt","year":"2025","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0895-4356(99)00102-X","article-title":"Analysis of case-cohort designs","volume":"52","author":"Barlow","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12933-021-01348-w","article-title":"Triglyceride-rich lipoprotein and LDL particle subfractions and their association with incident type 2 diabetes: the PREVEND study","volume":"20","author":"Sokooti","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011433","article-title":"Trajectories of blood lipid concentrations over the adult life course and risk of cardiovascular disease and all-cause mortality: observations from the Framingham Study over 35 years","volume":"8","author":"Duncan","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2026.10.002_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2026.10.002_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103341","article-title":"Impaired HDL antioxidant and anti-inflammatory functions are linked to increased mortality in acute heart failure patients","volume":"76","author":"Pammer","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.atherosclerosis.2016.01.012","article-title":"High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort","volume":"246","author":"McGarrah","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hrthm.2026.10.002_bib33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ncpcardio0500","article-title":"Antiatherogenic small, dense HDL\u2014guardian angel of the arterial wall?","volume":"3","author":"Kontush","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.10.002_bib34","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1038\/s41598-021-82998-4","article-title":"The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation","volume":"11","author":"Minami-Takano","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.hrthm.2026.10.002_bib35","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/eurheartj\/ehab705","article-title":"Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study","volume":"43","author":"Wadstr\u00f6m","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.10.002_bib36","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.hrthm.2024.05.044","article-title":"Low remnant cholesterol and the subsequent risk of new-onset atrial fibrillation: A prospective cohort study","volume":"21","author":"Chen","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.10.002_bib37","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.hrthm.2024.10.030","article-title":"Remnant cholesterol and new-onset atrial fibrillation: The Atherosclerosis Risk in Communities study","volume":"22","author":"Ouyang","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.10.002_bib38","first-page":"2243","article-title":"The association between remnant cholesterol levels and the risk of atrial fibrillation: A deeper dive into a dramatic reversal in findings","volume":"22","author":"DeSantis","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.10.002_bib39","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.jacc.2021.01.053","article-title":"Remnant Cholesterol Is Just Another Word for Triglycerides When Calculating LDL-C Using the Friedewald Formula","volume":"77","author":"Szili-Torok","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib40","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41467-023-36231-7","article-title":"Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank","volume":"14","author":"Julkunen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2026.10.002_bib41","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/ATVBAHA.116.308305","article-title":"Remnant Cholesterol and Triglyceride-Rich Lipoproteins in Atherosclerosis Progression and Cardiovascular Disease","volume":"36","author":"Varbo","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib42","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies\u2014a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.10.002_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2188\/jea.JE20200305","article-title":"Exploring the causal roles of circulating remnant lipid profile on cardiovascular and cerebrovascular diseases: Mendelian randomization study","volume":"32","author":"Si","year":"2022","journal-title":"J Epidemiol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib44","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00702.2020","article-title":"Coronary heart disease and atrial fibrillation: a vicious cycle","volume":"320","author":"Liang","year":"2021","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"10.1016\/j.hrthm.2026.10.002_bib45","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41569-023-00857-3","article-title":"The bidirectional association between atrial fibrillation and myocardial infarction","volume":"20","author":"Frederiksen","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1582-4934.2008.00219.x","article-title":"Atrial extracellular matrix remodelling in patients with atrial fibrillation","volume":"12","author":"Polyakova","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.hrthm.2026.10.002_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221145181","article-title":"Collagen Remodeling and Fatty Acid Regulation Biomarkers in Understanding the Molecular Pathogenesis of Atrial Fibrillation","volume":"28","author":"Odeh","year":"2022","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.hrthm.2026.10.002_bib48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrcardio.2017.31","article-title":"Hypertriglyceridaemia and risk of coronary artery disease","volume":"14","author":"Reiner","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","article-title":"Meta-analysis of cohort and case\u2013control studies of type 2 diabetes mellitus and risk of atrial fibrillation","volume":"108","author":"Huxley","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib50","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1472-8206.2009.00739.x","article-title":"Lipid modification in type 2 diabetes: the role of LDL and HDL","volume":"23","author":"Verg\u00e8s","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.hrthm.2026.10.002_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100796","article-title":"HDL meets triglyceride","volume":"66","author":"Akcan","year":"2025","journal-title":"J Lipid Res"},{"key":"10.1016\/j.hrthm.2026.10.002_bib52","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.3390\/ijms23169417","article-title":"Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels","volume":"23","author":"Nelson","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hrthm.2026.10.002_bib53","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1038\/s41467-021-25703-3","article-title":"Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease","volume":"12","author":"Schmidt","year":"2021","journal-title":"Nat Commun"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126028626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126028626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:43:29Z","timestamp":1793231009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126028626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"alternative-id":["S1547527126028626"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.10.002","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear magnetic resonance-derived lipoprotein profile and risk of atrial tachyarrhythmia recurrence after catheter ablation: a case-cohort design within the PREDIMAR trial","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}